Pain Management

Ubrogepant is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved by the agency for the acute treatment of migraine.

Jeffrey Fudin, PharmD, DAIPM, FASHP, FFSMB, CEO of Remitigate, discusses how opioid and pain management guidelines have evolved. This video was filmed at the 2019 ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada.

A Multimodal Analgesic Approach Can Improve the Quality of Analgesia and Reduce Adverse Effects.

"Opioids are associated with significant side effects in some patients, side effects that can frequently be managed by ancillary therapies."

The FDA has previously sent warning letters to other companies for illegally selling CBD products that had claimed to prevent, diagnose, mitigate, treat, or cure serious diseases, such as cancer.

These health care professionals should receive education on how to prevent opioid misuse.

As approved delegates, techs can assist pharmacists by reviewing prescription drug monitoring programs.

Why is this woman in opioid withdrawal despite high dose methadone administration?

The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab, as well as experts that pharmacists can contact with questions regarding buying, selling, and marketing.

Jesica Mills, PharmD, MBA, discusses the opportunities pharmacists have to help their patients with hemp-derived CBD products. This video was filmed at the 2019 NCPA Annual Convention in San Diego.

Four pharmaceutical distributors have agreed to settle federal litigation related to the ongoing opioid epidemic for a collective $260 million, less than a day before a federal trial was set to begin in Ohio.

A new Health Trends study released by Quest Diagnostics has highlighted many physicians' overconfidence in their ability to identify and treat substance misuse, as well as concerns that the drug gabapentin is increasingly being misused.

The agency's move opens the door to more versions of the neuropathic pain reliever.

Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.

OTC case studies for headache treatment during pregnancy and lower-back pain remedies.

Pharmacists can help patients by recommending the most effective and safest therapies.

All 3 are essential in the fight against the opioid crisis, but they need to forge alliances and work together.

Analgesic Alternatives May Help Reduce Unnecessary Exposure to Opioid Medications

Calcitonin gene-related peptide inhibitors are integral to preventing these powerful headaches.

Because of potential adverse reactions, careful product selection for both acute injuries and chronic conditions is key.

This month's case studies include a potential drug-related problem and a possible overdose.

Pharmacists can guide patients in the appropriate and safe use of these products and direct them to seek medical care when warranted.

Brown bagging is an essential educational and safety tool for patients who are suffering.

This method may optimize pain control and could be an answer to the opioid crisis.

The results of a study of almost 500,000 women indicate that taking paracetamol or other painkillers during pregnancy does not increase the risk of asthma in children.